Organic acids and derivatives
Medchemexpress LLC LGD-6972 | 1207989-09-0 | MFCD28411370 | 98.0% | 702.90 g/mol | C43H46N2O5S | 25MG
LGD-6972 is an orally active, selective glucagon receptor (GCGR) antagonist used for research into glucose regulation and type 2 diabetes. It inhibits GCGR signaling to reduce glucagon-stimulated cAMP and hepatic glucose production; reported molecular formula C43H46N2O5S, molecular weight 702.9 g/mol, CAS 1207989-09-0, and typical supplied purity is 98.0%.
- Selective oral GCGR antagonist for glucose regulation research.
- Reduces glucagon-stimulated cAMP and hepatic glucose production.
- Demonstrated glucose-lowering activity in preclinical and clinical studies.
- Available in multiple salt forms and small-scale pack sizes for laboratory use.
- High purity suitable for analytical and biological assays.
eMolecules 1131576-06-1 | Medchem Express | Tramiprosate-d6 | 1mg | 721309673 | HY-14602S | MFCD06656341 | 145.21 | C3H9NO3S
AbaChemScene | 7-Chloro-4-aminoquinoline | 100mg | 391074962 | CS-D0096 | 1198-40-9 | MFCD00828822 | 178.620 | C9H7ClN2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Acamprosate-d3 calcium | 1225580-94-8 | MFCD09839803 | 98.0% | 203.26 g/mol | C5H7D3CaNO4S+ | 10 MG
Acamprosate-d3 calcium is the deuterium-labeled form of acamprosate calcium supplied as a stable isotope reference standard for analytical and research use. It acts as an internal standard for quantitative mass spectrometry and retains the pharmacological profile of acamprosate as a GABA receptor agonist and modulator of glutamatergic systems.
- Deuterium-labeled internal standard for analytical quantitation.
- Suitable for LC-MS and GC-MS assays.
- High purity, 98.0%.
- Provided as a 10 mg quantity.
- CAS number 1225580-94-8 for unambiguous identification.
- Appropriate for method development, validation, and pharmacokinetic studies.
eMolecules 685533-92-0 | 1-N,1-N-Diethyl-4-(trifluoromethyl)benzene-1,2-diamine | Oakwood Chemical | MFCD06655605 | 232.250 | C11H15F3N2 | 95.000 | CCN(CC)c1ccc(cc1N)C(F)(F)F | 1g | 537703173
1-N,1-N-Diethyl-4-(trifluoromethyl)benzene-1,2-diamine | Oakwood Chemical | 685533-92-0 | MFCD06655605 | 232.250 | C11H15F3N2 | 95.000 | CCN(CC)c1ccc(cc1N)C(F)(F)F | 1g | 537703173
Medchemexpress LLC HY-B0351 5g Medchemexpress, Taurine 2-Aminoethanesulfonic acid CAS:107-35-7 Purity:98%
Medchemexpress,HY-B0351 5g Taurine 2-Aminoethanesulfonic acid CAS:107-35-7 Formula:C2H7NO3S Purity:98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
![eMolecules AstaTech / TERT-BUTYL 6-(TOSYLOXY)-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE / 0.1g / 793957256 / AT23473 / 95.000 / 1558037-97-0 / [null] / 367.460 / C18H25NO5S](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502461246.JPG-250.jpg)
eMolecules AstaTech / TERT-BUTYL 6-(TOSYLOXY)-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE / 0.1g / 793957256 / AT23473 / 95.000 / 1558037-97-0 / [null] / 367.460 / C18H25NO5S
AstaTech / TERT-BUTYL 6-(TOSYLOXY)-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE / 0.1g / 793957256 / AT23473 / 95.000 / 1558037-97-0 / [null] / 367.460 / C18H25NO5S
Medchemexpress LLC ASN007 benzenesulfonate (ERK-IN-3 benzenesulfonate) | 2055597-39-0 | 99.7% | 632.11 | 100 MG
ASN007 (ERK-IN-3) benzenesulfonate is a potent and orally active inhibitor of ERK. It demonstrates potent inhibition of ERK1/2 with low single-digit nanomolar IC50 values. This compound exhibits significant antiproliferative activity against various tumor cells and is suitable for research into cancers driven by RAS mutations.
- Potent and orally active ERK inhibitor
- Inhibits ERK1/2 with low single-digit nM IC50 values
- Exhibits significant antiproliferative activity against various tumor cells
- Useful for research of cancers driven by RAS mutations
- Inhibits the phosphorylation of ERK1/2 substrates (e.g., RSK1, FRA1, Elk1) in various cell lines
- Induces G0/G1 phase cell cycle arrest in various cells
- Significantly inhibits tumor growth and shows good tolerance in nude mice bearing BRAF and KRAS mutant xenograft tumors
eMolecules 2055597-39-0 | Medchem Express | ASN007 (benzenesulfonate) | 5mg | 686240454 | HY-136579A | 632.11 | C28H31ClFN7O5S
Medchem Express | SU9516 | 5mg | 446269187 | HY-18629 | 377090-84-1 | MFCD17010284 | 241.250 | C13H11N3O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 169751-73-9 | Ambeed | tert-Butyl 14-(tosyloxy)-36912-tetraoxatetradecan-1-oate | 100mg | 633662538 | A388377 | MFCD27977499 | 462.55 | C21H34O9S
Medchem Express | Glycolithocholic acid (sodium) | 5mg | 758391287 | HY-116374A | 24404-83-9 | MFCD00036744 | 455.615 | C26H42NNaO4
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC ASN007 benzenesulfonate | 2055597-39-0 | 99.7% | 632.11 | C28H31ClFN7O5S | 5 MG
ASN007 benzenesulfonate is the benzenesulfonate salt of ASN007, a potent ERK1/2 inhibitor used for preclinical research into MAPK/ERK pathway biology and cancers driven by RAS mutations. It is supplied as a high-purity research reagent for in vitro and in vivo studies.
- Potent ERK1/2 inhibition with low single-digit nanomolar IC50 values.
- Suitable for research of RAS- and MAPK/ERK-driven cancer models.
- Benzenesulfonate salt form for improved handling and stability.
- High purity (≈99.7%) suitable for biological studies.
- Molecular weight 632.11 and formula C28H31ClFN7O5S.
- Available in small reagent pack sizes for dose-response and pilot studies.
Medchemexpress LLC Pulrodemstat benzenesulfonate | 2097523-60-7 | 99.6% | 10 MG
Pulrodemstat benzenesulfonate (CC-90011) is a potent, selective, reversible, and orally active inhibitor of lysine specific demethylase-1 (LSD1) with an IC50 of 0.25 nM. It exhibits less enzymatic inhibition against LSD2, MAO-A, and MAO-B. This compound induces differentiation in acute myeloid leukemia (AML) and small cell lung cancer (SCLC) cells and demonstrates potent anticancer activity.
- Potent, selective, reversible, and orally active LSD1 inhibitor
- IC50 of 0.25 nM for LSD1
- Induces acute myeloid leukemia (AML) and small cell lung cancer (SCLC) cell differentiation
- Potent anticancer activity
- Less enzymatic inhibition against LSD2, MAO-A, and MAO-B
eMolecules 512-35-6 | Benzenesulfonic anhydride | Combi-Blocks | MFCD00054601 | 298.330 | C12H10O5S2 | 96.000 | O=S(=O)(OS(=O)(=O)c1ccccc1)c1ccccc1 | 1g | 267199818
Benzenesulfonic anhydride | Combi-Blocks | 512-35-6 | MFCD00054601 | 298.330 | C12H10O5S2 | 96.000 | O=S(=O)(OS(=O)(=O)c1ccccc1)c1ccccc1 | 1g | 267199818
Chemscene ChemScene | Ethoxydiphenylphosphine | 500G | CS-W010380 | 0.97 | 719-80-2| MFCD00009087 | 230.25
ChemScene | Ethoxydiphenylphosphine | 500G | CS-W010380 | 0.97 | 719-80-2| MFCD00009087 | 230.25
Medchemexpress LLC Pulrodemstat benzenesulfonate | 2097523-60-7 | 99.6% | 50 MG
Pulrodemstat benzenesulfonate is a potent, selective, reversible, and orally active inhibitor of lysine specific demethylase-1 (LSD1) with an IC50 of 0.25 nM. It induces differentiation in acute myeloid leukemia (AML) and small cell lung cancer (SCLC) cells, demonstrating potent anticancer activity.
- Potent, selective, reversible, and orally active LSD1 inhibitor
- Less enzymatic inhibition against LSD2, MAO-A, and MAO-B
- Induces differentiation in AML and SCLC cells
- Demonstrates potent anticancer activity
- Shows potent induction of CD11b in THP-1 cell line
- Exhibits antiproliferative activity in AML kasumi-1 cells
- Suppression of GRP observed in a dose-dependent manner
- Potent antiproliferative activity in SCLC cells
Matrix Scientific 3-BUTYNYL P-TOLUENESULFONAT-5G
3-Butynyl p-toluenesulfonate, 98%; 5g,C11H12O3S, MFCD00041687, mw 224.28, [23418-85-1]